论文部分内容阅读
磺脲类(SU)口服降糖药物治疗非胰岛素依赖型糖尿病(NIDDM)出现继发性失效,是临床治疗中一个常见而棘手的问题,发病机制尚未完全阐明。现就其发生机理的研究和临床治疗对策综述如下。
Oral hypoglycemic agents of sulfonylurea (SU) in the treatment of non-insulin dependent diabetes mellitus (NIDDM) secondary failure, is a common and difficult clinical treatment problems, the pathogenesis has not been fully elucidated. Now on the mechanism of its research and clinical treatment strategies are summarized below.